SOLACI Research | SOLACI’s Innovative Research Area

We have the pleasure to announce the creation of SOLACI’s research department under the name “SOLACI Research”, aimed at fostering clinical research in the region by creating registries, developing local guidelines, core-lab, consultation and training sessions coordinated by SOLACI.

SOLACI RESEARCH

All interventional cardiologists meeting our basic requirements willing to participate can join the research department as collaborators.

Basic Requirements:

  1. To practise interventional cardiology in Latin America
  2. To have at least 3 indexed publications in Pubmed MEDLINE as author/ or co-author.

To join our team, please send your short CV to research@solaci.org, including:

  1. Your Pubmed MEDLINE Publications.
  2. A list of no more than 3 areas of interest in the field (e.g.: 1- TAVR 2- CTO, 3- left atrial closure). These specifications will be of great use to be considered for the pertinent research sub-groups within SOLACI Research.

We appreciate the support of the Latin American medical community (either residing in the continent or in other latitudes) to develop this innovative important project, essential to the promotion and growth of interventional cardiology in the region.

Looking forward to your collaboration

Sincerely,

Dr. Pablo Lamelas
Dr. SOLACI Research Coordinator, SOLACI Research Department

Dr. José Armando Mangione
SOLACI President


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

SELUTION Sirolimus-Eluting Balloon For De Novo Coronary Lesions – New Evidence and Clinical Perspectives

The Latin American Society of Interventional Cardiology invites you to join a new virtual scientific event focused on the latest evidence and clinical perspectives...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...